Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from Clinical (Oncology: Other)

  • CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of <sup>89</sup>Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
    You have access
    CD8-Targeted PET Imaging of Tumor-Infiltrating T Cells in Patients with Cancer: A Phase I First-in-Humans Study of 89Zr-Df-IAB22M2C, a Radiolabeled Anti-CD8 Minibody
    Michael D. Farwell, Raymond F. Gamache, Hasan Babazada, Matthew D. Hellmann, James J. Harding, Ron Korn, Alessandro Mascioni, William Le, Ian Wilson, Michael S. Gordon, Anna M. Wu, Gary A. Ulaner, Jedd D. Wolchok, Michael A. Postow and Neeta Pandit-Taskar
    Journal of Nuclear Medicine May 1, 2022, 63 (5) 720-726; DOI: https://doi.org/10.2967/jnumed.121.262485
  • You have access
    Dual-tracer PET/CT protocol with [18F]-FDG and [68Ga]Ga-FAPI-46 for cancer imaging - a proof of concept.
    Katrin S Roth, Conrad-Amadeus Voltin, Lutz van-Heek, Simone Wegen, Klaus Schomaecker, Thomas Fischer, Simone Marnitz, Alexander E. Drzezga and Carsten Kobe
    Journal of Nuclear Medicine April 14, 2022, jnumed.122.263835; DOI: https://doi.org/10.2967/jnumed.122.263835
  • You have access
    The Importance of Training, Accreditation and Guidelines for The Practice of Theranostics: The Australian Perspective
    Sze Ting Lee, Louise M Emmett, David A. Pattison, Michael S Hofman, Dale L. Bailey, Melissa Latter, Roslyn J Francis and Andrew Scott
    Journal of Nuclear Medicine April 7, 2022, jnumed.122.263996; DOI: https://doi.org/10.2967/jnumed.122.263996
  • Open Access
    Temporary reactive response of axillary lymph nodes to COVID-19 vaccination on 18F-rhPSMA-7.3 PET/CT in patients with prostate cancer
    Susan Notohamiprodjo, Matthias Eiber, Christian Lohrmann and Wolfgang Andreas Weber
    Journal of Nuclear Medicine March 3, 2022, jnumed.121.263758; DOI: https://doi.org/10.2967/jnumed.121.263758
  • You have access
    Imaging of C-X-C Motif Chemokine Receptor 4 Expression in 690 Patients with Solid or Hematologic Neoplasms using 68Ga-PentixaFor PET
    Andreas K. Buck, Alexander Haug, Niklas Dreher, Alessandro Lambertini, Takahiro Higuchi, Constantin Lapa, Alexander Weich, Martin G. Pomper, Hans-Jürgen Wester, Anja Zehnder, Andreas Schirbel, Samuel Samnick, Marcus Hacker, Verena Pichler, Stefanie Hahner, Martin Fassnacht, Hermann Einsele, Sebastian Serfling and Rudolf A Werner
    Journal of Nuclear Medicine March 3, 2022, jnumed.121.263693; DOI: https://doi.org/10.2967/jnumed.121.263693
  • You have access
    Biodistribution and radiation dosimetry of intraperitoneally administered 124I-omburtamab in patients with desmoplastic small round cell tumors
    Milan Grkovski, Shakeel Modak, Pat B. Zanzonico, Jorge A. Carrasquillo, Steven M. Larson, John Laurence Humm and Neeta Pandit-Taskar
    Journal of Nuclear Medicine December 2, 2021, jnumed.121.262793; DOI: https://doi.org/10.2967/jnumed.121.262793
  • You have access
    Pitfalls and common findings in 68Ga-FAPI-PET – A pictorial analysis
    Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler and Christoph Rischpler
    Journal of Nuclear Medicine October 7, 2021, jnumed.121.262808; DOI: https://doi.org/10.2967/jnumed.121.262808
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire